Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Oct 8 - Oct 13
Market Projections and Access Considerations Analyst projections suggest the GLP-1 market could reach $150 billion by 2030, driven by expanding indications and growing patient populations ^42
Glick D, Barth S, Macleod KF
H ims & Hers is shaking up the weight loss drug market by offering affordable compounded GLP-1 injections
Toujeo specifically enters the picture when a patient needs basal insulin and either has already tried and failed GLP-1 therapy, has a contraindication to GLP-1 drugs, has Type 1 diabetes, or has very advanced Type 2 diabetes with negligible beta cell function
Because BPC-157 is a potent peptide, a licensed doctor must prescribe it before you can begin treatment
US$ 22.87
US$ 27.13
US$ 24.55
